WVE Insider Trading Activity and SEC Form 4 Filings
WVE insider trading summary
Over the past 12 months, insiders at Wave Life Sciences, Inc. (WVE) reported 46 sales worth $15.9M by 11 insiders and 5 open-market purchases worth $28.0M by 5 insiders on SEC Form 4. Net insider buying was $12.0M.
Latest WVE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Adrian Rawcliffe | Insider | Sell | $67K (12,700 @ $5.29) |
| Aug 11, 2026 | Ken Takanashi | Insider | Sell | $23K (3,864 @ $6.01) |
| Aug 11, 2026 | Aik Na Tan | Insider | Sell | $3K (432 @ $6.01) |
| Aug 11, 2026 | Heidi L Wagner | Insider | Sell | $42K (7,000 @ $6.01) |
| Feb 26, 2026 | Chris Francis | See Remarks | Sell | $229K (15,294 @ $15.00) |
| Feb 26, 2026 | Chris Francis | See Remarks | Sell | $270K (17,900 @ $15.09) |
| Feb 9, 2026 | Kyle Moran | Chief Financial Officer | Sell | $48K (3,588 @ $13.45) |
| Feb 9, 2026 | Chandra Vargeese | See Remarks | Sell | $43K (3,228 @ $13.45) |
| Feb 9, 2026 | Chris Francis | See Remarks | Sell | $25K (1,883 @ $13.45) |
| Feb 9, 2026 | Paul Bolno | President and CEO | Sell | $141K (10,480 @ $13.45) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.